26Jun 2021 by kmitch@duke.edu
Press Release: Regional Action through Data (RAD)

Press Release: Regional Action through Data (RAD)

Blog
Press Release June 26, 2021. The Global Health Innovation Center and Innovations in Healthcare at Duke University have partnered with Broadreach, the InterGovernmental Authority Development (IGAD), the West Africa Health Organization (WAHO), Jembi Health Systems, and with the United States Agency for International Development (USAID), to address the problem of the limited use of data to drive performance in healthcare service delivery to improve health and development outcomes in Sub-Saharan Africa. Our goals and objectives of this project are: To address the problem of the limited use of data to drive decision making through the introduction of disruptive technologies To equip and empower key stakeholders to make data-based healthcare delivery decisions, through aligned and harmonized data collection systems that will be used by regional and national partners for evidence-based decision-making…
Read More
18Jun 2021 by Melissa Slogan
THE G7 UNDERWHELMS, WITH NUMBERS THAT DON’T ADD UP

THE G7 UNDERWHELMS, WITH NUMBERS THAT DON’T ADD UP

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, June 18, 2021 High-income country confirmed dose total: 6 billion Upper-middle-income country total: 2.2 billion Lower-middle-income country total: 1.8 billion Low-income country total: 271 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 12.7 billion doses INSIGHTS The G7 underwhelms, with numbers that don’t add up Author: Andrea Taylor The G7 began their much-anticipated summit last week with a target to reach 1 billion doses of Covid-19 vaccine in pledged donations for low- and middle-income countries (LMICs). The result could be described as underwhelming (as well as unclear). To be fair, the US set a high bar early in the week, with a plan to donate 500 million Pfizer-BioNTech doses (working “with,” but not necessarily through, COVAX). It was going to be…
Read More
11Jun 2021 by Melissa Slogan
HOW CAN INDIA ADDRESS A POTENTIAL THIRD WAVE OF SARS-CV-2 INFECTIONS?

HOW CAN INDIA ADDRESS A POTENTIAL THIRD WAVE OF SARS-CV-2 INFECTIONS?

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, June 11, 2021 High-income country confirmed dose total: 6 billion Upper-middle-income country total: 2.2 billion Lower-middle-income country total: 1.4 billion Low-income country total: 271 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 12.2 billion doses INSIGHTS How can India address a potential third wave of SARS-CoV-2 infections? Author: Nikki Prattipati Starting mid-March 2021, India has become the epicenter of COVID-19 as a second wave of infections devastated the country. India reported 50 percent of global cases and 30 percent of global COVID-19 deaths, and an alarming rate of over 400,000 daily new cases at the height of the wave in early May 2021. While official projections estimate 29 million total infections and 360,000 deaths, low testing rates and the lack of available data lead some…
Read More
04Jun 2021 by Melissa Slogan
HOW DO COVID-19 VARIANTS IMPACT VACCINATIONS AND THE ABILITY TO END THE ACUTE PHASE OF THE PANDEMIC?

HOW DO COVID-19 VARIANTS IMPACT VACCINATIONS AND THE ABILITY TO END THE ACUTE PHASE OF THE PANDEMIC?

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, June 4, 2021 [caption id="attachment_1629" align="alignnone" width="300"] Coronavirus and DNA, virus mutation. New variant and strain of SARS CoV 2. Microscopic view. 3D rendering[/caption] High-income country confirmed dose total: 6 billion Upper-middle-income country total: 2.2 billion Lower-middle-income country total: 1.1 billion Low-income country total: 270 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 11.9 billion doses INSIGHTS How do COVID-19 variants impact vaccinations and the ability to end the acute phase of the pandemic? Author: Blen Biru Multiple COVID-19 genetic variants have been detected since the initial SARS-CoV-2 strain was found in China, the most significant of which are classified by the WHO as variants of concern or variants of interest, depending on their attributes and risk level. The variants of concern are…
Read More